Harel Insurance Investments & Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$478K Buy
9,962
+2,287
+30% +$98.3K ﹤0.01% 250
2026
Q1
$282K Buy
+7,675
New +$364K ﹤0.01% 270
2025
Q4
Sell
-3,370
Closed -$187K 459
2025
Q3
$187K Sell
3,370
-9,027
-73% -$528K ﹤0.01% 289
2025
Q2
$856K Sell
12,397
-549,790
-98% -$37.4M 0.01% 183
2025
Q1
$39.5M Buy
+562,187
New +$46.4M 0.52% 48
2024
Q4
Sell
-2,759
Closed -$329K 504
2024
Q3
$329K Sell
2,759
-1,100
-29% -$147K 0.01% 196
2024
Q2
$554K Sell
3,859
-233
-6% -$30.9K 0.01% 174
2024
Q1
$525K Sell
4,092
-553,562
-99% -$65.9M 0.01% 165
2023
Q4
$57.7M Buy
557,654
+550
+0.1% +$54.4K 1.01% 31
2023
Q3
$50.7M Buy
557,104
+554,200
+19,084% +$48.8M 1% 30
2023
Q2
$232K Sell
2,904
-8,706
-75% -$711K 0.01% 299
2023
Q1
$919K Sell
11,610
-4,770
-29% -$338K 0.02% 177
2022
Q4
$1.1M Buy
16,380
+4,428
+37% +$260K 0.02% 154
2022
Q3
$599K Buy
11,952
+10,382
+661% +$556K 0.01% 196
2022
Q2
$87K Sell
1,570
-1,670
-52% -$92.7K ﹤0.01% 426
2022
Q1
$180K Sell
3,240
-20,430
-86% -$1.05M ﹤0.01% 359
2021
Q4
$1.32M Buy
23,670
+7,822
+49% +$424K 0.02% 156
2021
Q3
$761K Buy
15,848
+3,448
+28% +$167K 0.02% 179
2021
Q2
$1.69M Buy
+12,400
New +$481K 0.04% 221
2019
Q1
Sell
-120
Closed -$3K 489
2018
Q4
$3K Buy
+120
New +$2.67K ﹤0.01% 442
2016
Q3
Sell
-480
Closed -$13K 609
2016
Q2
$13K Buy
+480
New +$13.2K ﹤0.01% 533

Other funds holding NVO

Harel Insurance Investments & Financial Services's NVO Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services increased its Novo Nordisk (NVO) stake by 30% in Q2 2026, buying an estimated $98.3K and bringing the position to 9,962 shares worth $478K. The position accounts for ﹤0.01% of the portfolio, ranked #250.

Harel Insurance Investments & Financial Services first reported a position in NVO in Q2 2016 and has held it in 21 quarters since. The position peaked at $57.7M in Q4 2023. 1,041 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 9,962 shares of Novo Nordisk worth $478K as of Q2 2026.
  • Harel Insurance Investments & Financial Services bought 2,287 Novo Nordisk shares in Q2 2026, an estimated $98.3K.
  • Novo Nordisk made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #250 holding.
  • Harel Insurance Investments & Financial Services first reported a position in Novo Nordisk in Q2 2016 and has held it in 21 quarters since.
  • Harel Insurance Investments & Financial Services's Novo Nordisk position peaked at $57.7M in Q4 2023.
  • 1,041 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.